Can two radiation therapies team up to fight liver cancer?

NCT ID NCT04518748

First seen Jul 31, 2026 ยท Last updated Jul 31, 2026

Summary

This trial is testing whether combining two types of radiation therapy can safely treat liver cancer that cannot be removed with surgery. The approach uses Y-90 microspheres delivered directly to the liver, followed by targeted external radiation (SBRT). The study also uses PET-CT imaging to help plan the radiation more precisely. The main goal is to check the safety of this combination and see how it affects liver function.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Yttrium-90 (Y-90) microspheres given via selective internal radiation therapy (SIRT), followed by stereotactic body radiation therapy (SBRT)
What this could lead to
If safe and effective, this combination could offer a new way to treat liver cancer that cannot be removed surgically, potentially improving local control of tumors.
What could go wrong
This is an early-phase trial focused on safety, so the combination may not prove more effective than standard treatments. There is a risk of liver damage or other side effects from the radiation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Michigan Rogel Cancer Center

    Ann Arbor, Michigan, 48109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.